Mount Sinai Medical Center is a clinical research site located in Miami, Florida, United States 33140.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
Mount Sinai Medical Center has participated in 10 clinical trials with 1 currently active.
Therapeutic areas: mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Neoplasms, Male, Urogenital Neoplasms.
Sponsors: Pathos AI, Inc., W.L.Gore & Associates, C. R. Bard.
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Mount Sinai Medical Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mount Sinai Medical Center has 10 clinical trials on record, with 1 currently active. Their work covers mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Neoplasms, Male, Urogenital Neoplasms.
Yes — Mount Sinai Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.